These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4378175)

  • 1. An evaluation of estrogenic substances in the treatment of cerebral vascular disease. Report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
    Circulation; 1966 May; 33(5 Suppl):II3-9. PubMed ID: 4378175
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogenic therapy in men with ischemic cerebrovascular disease: effect on recurrent cerebral infarction and survival. Final report of the Veterans Administration cooperative study of atherosclerosis, neurology section.
    Stroke; 1972; 3(4):427-33. PubMed ID: 4340244
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
    Stroke; 1973; 4(4):684-93. PubMed ID: 4723698
    [No Abstract]   [Full Text] [Related]  

  • 4. ESTROGEN TREATMENT OF PATIENTS WITH CHRONIC BRAIN SYNDROME ASSOCIATED WITH CEREBRAL ARTERIOSCLEROSIS.
    LEFSHITZ K; KLINE NS
    Am J Psychiatry; 1965 Sep; 122():329-31. PubMed ID: 14327479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
    Danilova IN; Neretin VIa; Nesterova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention after ischemic stroke. High risk patients need special protection].
    MMW Fortschr Med; 2004; 146 Suppl 1():10-1. PubMed ID: 15493413
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of estrogens for therapy of myocardial infarction in middle-age men.
    STAMLER J; PICK R; KATZ LN; PICK A; KAPLAN BM; BERKSON DM; CENTURY D
    JAMA; 1963 Feb; 183():632-8. PubMed ID: 13983325
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study.
    Ebert RV
    JAMA; 1969 Mar; 207(12):2263-7. PubMed ID: 4885975
    [No Abstract]   [Full Text] [Related]  

  • 9. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
    Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
    Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PATHOGENESIS OF MYOCARDIAL AND CEREBRAL INFARCTION: NODULAR ARTERIOSCLEROSIS.
    PICKERING G
    Br Med J; 1964 Feb; 1(5382):517-29. PubMed ID: 14101997
    [No Abstract]   [Full Text] [Related]  

  • 11. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
    Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention of atherosclerosis in routine practice].
    Christ M; Diener HC; Kurth T; Diehm C; Wehling M
    Internist (Berl); 1998 Oct; 39(10):1080-97. PubMed ID: 9827385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis.
    Ovbiagele B; Lynn MJ; Saver JL; Chimowitz MI;
    Cerebrovasc Dis; 2007; 24(2-3):283-8. PubMed ID: 17646693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of atherothrombotic and lacunar infarction in the elderly].
    Ibayashi S; Watanabe M; Omae T; Fujishima M
    Nihon Ronen Igakkai Zasshi; 1998 Oct; 35(10):730-4. PubMed ID: 9893476
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nervous disease & Ca antagonist].
    Otomo E
    No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemostatic effect of conjugated estrogenic substances].
    Toriyama M; Hoshino T; Sato Y
    Jibiinkoka; 1967 Mar; 39(3):333-6. PubMed ID: 4294843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum lipid-lowering drugs following myocardial infarction].
    Schettler G
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of stroke in TIAs with a cerebral infarct on CT.
    Dávalos A
    J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):427-8. PubMed ID: 8482971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.